InvestorsHub Logo

GS1

Followers 115
Posts 4767
Boards Moderated 0
Alias Born 07/11/2010

GS1

Re: zoomboom post# 112293

Sunday, 03/29/2015 11:55:14 PM

Sunday, March 29, 2015 11:55:14 PM

Post# of 130502
No doubt it is best hire. Just look at the work he has done at ALZA which was acquired by J&J by putting together assets that would attract BP. Also Cell Therapeutics (NASDAQ:CTIC) Milan, Italy factory asset sales when he was with Adjuvant...I could go on and on.... The man knows business.

Also this is confirmation that Lympro developement is on track with this hiring otherwise they wouldn't have hired him and neither he would have taken position with the company.

Just wait until univariate algorithmic model for Lympro comes out, Psychogenics has been doing this for years...and BOOOM. This model help identify additional biomarkers that are otherwise not visible using standard methods...Just watch..It is called Artificial Intelligence.

PsychoGenics has developed several advanced machine learning approaches which are uniquely suited to inferring relationships within data sets where the number of features (e.g., observable readout) for individual samples (e.g., specific animals) is much greater than the number of samples themselves – this is a typical situation encountered when analyzing gene expression profiles or outputs from many modern high-throughput screening platforms, including PsychoGenics’ proprietary hardware. We can provide our partners with access to the models that we build from their data, thus providing greater insight into how a particular model behaves if some data are withheld, added or modified within the data set.

http://www.psychogenics.com/analysis.html